LSE •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/07/2026 10:45
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeLSE
Market Capitalization333.41 mln
Float702 mln
Earnings Date09/24/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-3.59
Highly reliable
Relative Strength
32
/ 100
Underperforming
Debt / Equity
6.30
Extremely leveraged
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Allergy Therapeutics plc is a UK-based biotechnology company founded in 1998 that specializes in treating and diagnosing allergic conditions across Europe and beyond. The company offers a range of established allergy treatments, including injections and oral therapies targeting reactions to pollen, insect venom, and dust mites. It is also advancing two promising pipeline products: a grass pollen immunotherapy and a short-course peanut allergy vaccine.
